🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
This phase I clinical trial evaluates the safety and feasibility of adminis...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2017-07-26
Trial ID
NCT03240861
This is a dual arm (arm 1 and arm 2) multi-centric non-randomized (prospect...
Status
Not Yet Recruiting
Location
UZ Gent
Start Date
2024-09-01
Trial ID
NCT05973825
Treatments Being Tested
The proposed clinical study is a Phase 1/2a trial to investigate the safety...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2023-06-21
Trial ID
NCT05672459
This phase I trial compares the effect of lutetium Lu 177 (177\^Lu)-prostat...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-03-06
Trial ID
NCT07219147
This phase I trial tests the safety and side effects of B-cell activating f...
Status
Not Yet Recruiting
Location
City of Hope Medical Center
Start Date
2027-04-17
Trial ID
NCT07758673
Treatments Being Tested
This phase I/IIa trial studies the side effects and best dose of gene-modif...
Status
Active Not Recruiting
Location
Roswell Park Cancer Institute
Start Date
2017-07-14
Trial ID
NCT02650986
Systemic Sclerosis is a disease that may be caused by the immune system rea...
Status
Completed
Location
The Methodist Hospital
Start Date
1999-06
Trial ID
NCT00058578
Treatments Being Tested
Dendritic cells vaccinations are increasingly used in order to develop anti...
Status
Unknown
Location
Cellule de Promotion de la recherche clinique
Start Date
2009-11
Trial ID
NCT01146262
Treatments Being Tested
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Withdrawn
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-04-15
Trial ID
NCT06094842